US Patent 12006365 Human anti-semaphorin 4D antibody
Patent 12006365 was granted and assigned to Vaccinex, Inc on June, 2024 by the United States Patent and Trademark Office.
All edits
Edits on 13 Jun, 2024
Golden AI
Edits made to:
Infobox (+18 properties)
Article (+246 characters)
US Patent 12006365 Human anti-semaphorin 4D antibody
Article
Patent abstract
Compositions and method are provided for treating diseases associated with semaphorin-4D (SEMA4D) pathology, including autoimmune diseases, inflammatory diseases, cancers, neuroinflammatory disorders and neurodegenerative diseases.
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
Angelica Cornelison0
Ernest S. Smith0
Maria Scrivens0
Mark Paris0
Maurice Zauderer0
Date of Patent
June 11, 2024
0Patent Application Number
178133750
Date Filed
July 19, 2022
0Patent Citations
Patent Primary Examiner
Find more entities like US Patent 12006365 Human anti-semaphorin 4D antibody
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
